Skip to main content

Month: February 2023

Freshii Obtains Final Order of the Court Approving Arrangement with Foodtastic

TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) — Freshii Inc. (TSX: FRII) (“Freshii” or the “Company”) today announced that it has obtained a final order from the Ontario Superior Court of Justice (Commercial List) approving the previously announced plan of arrangement under the Business Corporations Act (Ontario), pursuant to which Foodtastic Inc. has agreed to acquire all of the issued and outstanding shares in the capital of Freshii at a price of $2.30 in cash per share (the “Arrangement”). All of the conditions to the completion of the Arrangement have now been satisfied or waived, excluding any conditions that, by their terms, cannot be satisfied or waived until the effective date of the Arrangement. Completion of the Arrangement is expected to occur on or about February 22, 2023. About Freshii Since 2005, Freshii has established...

Continue reading

Vital Energy Announces Midland Basin Acquisition

Vital Energy Midland Basin Acquisition Pro Forma Acreage MapTULSA, OK, Feb. 14, 2023 (GLOBE NEWSWIRE) — Vital Energy, Inc. (NYSE: VTLE) (“Vital” or the “Company”) today announced the signing of a definitive purchase and sale agreement to acquire the assets of Driftwood Energy Operating, LLC (“Driftwood”), inclusive of all leasehold interests and hedges, in exchange for 1,578,948 shares of Vital common stock and $127.6 million of cash. The transaction is expected to close early April 2023 with an effective date of January 1, 2023, subject to customary closing conditions. Highlights:Accretive to Free Cash Flow1 and Net Asset Value1 per share and leverage neutral Current production of ~5,400 barrels of oil equivalent (“BOE”) per day (63% oil), ~50% next 12-month decline rate Extends...

Continue reading

First Quantum Minerals Reports Fourth Quarter and Year-End 2022 Results

(In United States dollars, except where noted otherwise) TORONTO, Feb. 14, 2023 (GLOBE NEWSWIRE) — First Quantum Minerals Ltd. (“First Quantum” or “the Company”) (TSX: FM) today reports results for the three months ended December 31, 2022 (“Q4 2022”) of net earnings attributable to shareholders of the Company of $117 million ($0.17 earnings per share) and adjusted earnings1 of $151 million ($0.22 adjusted earnings per share2). For the year-ended 2022, the Company reported net earnings attributable to shareholders of the Company of $1,034 million ($1.50 per share) and adjusted earnings1 of $1,064 million ($1.54 per share1). “2022 can be summarized as a challenging year for First Quantum and the mining industry as a whole. The year was characterized by volatile commodity prices and rising costs and interest rates, creating a challenging...

Continue reading

VPG Reports Fiscal 2022 Fourth Quarter and Twelve Month Results

MALVERN, Pa., Feb. 14, 2023 (GLOBE NEWSWIRE) — Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement technologies, today announced its results for its fiscal 2022 fourth quarter and twelve fiscal months ended December 31, 2022. Fourth Quarter Highlights:Revenues of $96.2 million increased 6.9% from a year ago Gross profit margin was 41.2%, as compared to 38.7% a year ago Adjusted gross profit margin* was 41.5%, as compared to 40.3% a year ago Operating margin was 13.6%, as compared to 9.7% reported a year ago Adjusted operating margin* was 14.0%, as compared to 11.4% reported a year ago Diluted net earnings per share were $0.65, as compared to $0.44 reported a year ago Adjusted diluted net earnings per share* were $0.76, as compared to $0.56 reported a year ago EBITDA* was $15.4 million with an EBITDA margin*...

Continue reading

National Research Corporation Announces Fourth Quarter and Calendar Year 2022 Results

LINCOLN, Neb., Feb. 14, 2023 (GLOBE NEWSWIRE) — National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter and calendar year 2022. Regarding the Company’s 2022 annual performance, Kevin Karas, Chief Financial Officer, said, “We continued to grow revenue from core offerings, including our Human Understanding Program, resulting in 7% year-over-year revenue growth, partially offset by the phase out of our Canadian operations and other non-core offerings. Adoption of the Human Understanding Program has continued to increase with recent new client additions including St. Bernards Healthcare, Longstreet Clinic, and Legacy Community Health. In addition, we are proud to have recently received the Best in KLAS 2023 Award for Patient Experience Improvement. This recognition affirms our leadership...

Continue reading

Mullen Automotive Provides Fiscal First Quarter 2023 Business Update

Momentum Building for All Mullen Automotive BrandsMullen-GO (formerly I-GO) Now Available at Newgate Motor Group Newgate Motor Group is authorized distributor of Mullen-GO for Ireland and UK.BREA, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Mullen Automotive, Inc. (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced a financial update for its fiscal first quarter in 2023 ending December 31, 2022. Fiscal First Quarter 2023 and Recent Highlights Include:Mullen completed the purchase of ELMS’ (Electric Last Mile Solutions) assets in an all-cash $105 million purchase in November 2022 on the heels of the successful acquisition of a controlling interest in Bollinger Motors in September 2022. The Company has over $100 million in cash (includes restricted cash available for Company...

Continue reading

COMSTOCK RESOURCES, INC. REPORTS FOURTH QUARTER 2022 FINANCIAL AND OPERATING RESULTS

FRISCO, TX, Feb. 14, 2023 (GLOBE NEWSWIRE) — Comstock Resources, Inc. (“Comstock” or the “Company”) (NYSE: CRK) today reported financial and operating results for the quarter and year ended December 31, 2022. HighlightsGenerated free cash flow from operations of $673 million in 2022, including $129 million in the fourth quarter. Production in the fourth quarter increased 7% from last year to 1,445 MMcfe per day. Oil and gas sales, including realized hedging losses, were $2.3 billion in 2022 and $558 million in the fourth quarter and were 58% and 47% higher than 2021 and 2021’s fourth quarter. Cash flow from operations in 2022 was $1.7 billion or $6.21 per diluted share, including $434 million in the fourth quarter or $1.57 per diluted share. Adjusted EBITDAX in 2022 increased 72% to $1.9 billion...

Continue reading

Cemtrex Reports First Quarter 2023 Financial Results

Q1’23 Revenue Increased 27% to $12.0M, Security Segment Revenues Increased 61% to 7.0M in Q1’23 Gross Margin up 790 basis points to 42% in Q1’23 Management to Host Conference Call Today at 5:00 p.m. Eastern Time Brooklyn, NY, Feb. 14, 2023 (GLOBE NEWSWIRE) — – Cemtrex Inc. (NASDAQ: CETX, CETXP), an advanced security technology and industrial services company, has reported its financial and operational results for the first quarter ended December 31, 2022. Key First Quarter FY 2023 and Subsequent HighlightsRevenue for Q1’23 increased 27% to $12.0 million, compared to revenue of $9.4 million for Q1’22. Gross margin up 790 basis points to 42% in Q1’23 from 34% in the prior year quarter Operating loss for Q1’23 declined 41% to $2.0 million from $3.3 million in Q1’22. Completed divestiture of non-core assets to focus on accelerating...

Continue reading

NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023

PITTSBURGH, Feb. 14, 2023 (GLOBE NEWSWIRE) — NeuBase Therapeutics, Inc. (Nasdaq: NBSE) (“NeuBase” or the “Company”), a biotechnology platform company Drugging the Genome™ to address disease at the base level using a new class of precision genetic medicines, today reported its financial results for the three-month period ended December 31, 2022, and other recent developments. “We plan on leveraging our PATrOL™ platform to perform ‘nuclease free’ in vivo gene editing to restore healthy gene function. This technology complements the field of CRISPR/Cas editors, base editors, and prime editors, with the potential to address the majority of disease-causing mutations. We believe the high fidelity and lack of immunogenicity of our editing approach offer the possibility to address tissue turnover by redosing. Throughout calendar...

Continue reading

BlackLine Announces Fourth Quarter and Full Year Financial Results

LOS ANGELES, Feb. 14, 2023 (GLOBE NEWSWIRE) — BlackLine, Inc. (Nasdaq: BL), today announced financial results for the fourth quarter and full year ended December 31, 2022. “BlackLine reported solid financial results this quarter, as we continued to deliver against our goal of driving profitable growth,” said Marc Huffman, CEO of BlackLine. “Further, we recently announced innovative new solutions and expanded programs to support our customers as they continue on their digital transformation journeys. As we look ahead, we remain confident in our long-term strategy, market leadership and competitive positioning.” Fourth Quarter 2022 Financial HighlightsTotal GAAP revenues of $140.0 million, an increase of 21% compared to the fourth quarter of 2021. GAAP net income attributable to BlackLine of $11.3 million,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.